XML 23 R7.htm IDEA: XBRL DOCUMENT v3.22.4
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Cash flows from operating activities      
Net income before noncontrolling interests $ 248,385 $ 444,524 $ 308,503
Adjustments to reconcile net income to net cash provided by operating activities:      
Depreciation and amortization 7,797 6,933 6,625
Deferred income taxes 30,156 38,382 27,990
Asset impairment 1,413 0 871
Noncash lease expense 1,865 (1,931) (1,499)
Net investment (gain) loss on nonconsolidated investment securities 16,606 (2,315) (160)
Net (gain) loss on the tax receivable agreements (913) (358) 4,674
Loss on disposal of property and equipment 51 4 5
Amortization of debt issuance costs 440 421 422
Share-based compensation 41,532 39,649 37,027
Net investment (gain) loss of consolidated investment products 6,990 (19,748) (26,147)
Purchase of investments by consolidated investment products (335,647) (252,399) (191,274)
Proceeds from sale of investments by consolidated investment products 211,537 196,620 137,561
Net change in operating assets and liabilities of consolidated investment products including net investment income (45,970) 30,804 (36,587)
Change in assets and liabilities resulting in an increase (decrease) in cash:      
Accounts receivable 16,622 (15,962) (18,020)
Prepaid expenses and other assets 3,348 (3,164) (6,110)
Accounts payable and accrued expenses 16,458 (1,301) 1,622
Net cash provided by operating activities 312,610 398,551 318,677
Cash flows from investing activities      
Acquisition of property and equipment (6,637) (2,435) (2,049)
Payments For Leasehold Improvements 12,921 3,532 1,050
Proceeds from sale of investment securities 5,164 12,813 24,001
Purchase of investment securities (49,337) (33,820) (2,150)
Net cash provided by (used in) investing activities (63,731) (26,974) 18,752
Cash flows from financing activities      
Partnership distributions 57,199 93,189 85,805
Dividends paid (248,696) (274,740) (203,006)
Payment of debt issuance costs (543) 0 0
Proceeds from issuance of notes payable 90,000 0 0
Principal payments on notes payable (90,000) 0 0
Tax Receivable Agreement Payments 33,109 31,250 26,943
Net proceeds from issuance of common stock 0 46,928 63,027
Payment of costs directly associated with the issuance of Class A common stock 0 (244) (227)
Payments for Repurchase of Other Equity 0 (46,928) (63,027)
Taxes paid related to employee net share settlement (7,866) (9,246) (4,530)
Capital contributions to consolidated investment products, net 41,011 73,236 38,277
Net cash used in financing activities (306,402) (335,433) (282,234)
Net increase (decrease) in cash, cash equivalents and restricted cash (57,523) 36,144 55,195
Net cash impact of deconsolidation of CIPs 0 (34,823) 0
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Beginning Balance 200,771 199,450 144,255
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Ending Balance 143,248 200,771 199,450
Cash, cash equivalents and restricted cash      
Restricted cash 0 629 629
Noncash activity:      
Establishment of deferred tax assets 9,054 54,214 77,756
Establishment of amounts payable under tax receivable agreements 6,471 44,209 64,087
Increase in investment securities due to deconsolidation of consolidated investment products 9,970 20,900 1,469
Operating lease assets obtained in exchange for operating leases 32,055 20,830 3,425
Cash paid for:      
Interest on borrowings 10,299 10,210 10,255
Income tax 31,571 70,337 35,484
Consolidated Entity, Excluding VIE      
Cash, cash equivalents and restricted cash      
Cash and cash equivalents 114,832 189,226 154,987
Variable Interest Entity, Primary Beneficiary      
Cash, cash equivalents and restricted cash      
Cash and cash equivalents $ 28,416 $ 10,916 $ 43,834